Cargando…
Nanosystems, Drug Molecule Functionalization and Intranasal Delivery: An Update on the Most Promising Strategies for Increasing the Therapeutic Efficacy of Antidepressant and Anxiolytic Drugs
Depression and anxiety are high incidence and debilitating psychiatric disorders, usually treated by antidepressant or anxiolytic drug administration, respectively. Nevertheless, treatment is usually given through the oral route, but the low permeability of the blood–brain barrier reduces the amount...
Autores principales: | Antunes, Jéssica L., Amado, Joana, Veiga, Francisco, Paiva-Santos, Ana Cláudia, Pires, Patrícia C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10054777/ https://www.ncbi.nlm.nih.gov/pubmed/36986859 http://dx.doi.org/10.3390/pharmaceutics15030998 |
Ejemplares similares
-
Nanosystems for Brain Targeting of Antipsychotic Drugs: An Update on the Most Promising Nanocarriers for Increased Bioavailability and Therapeutic Efficacy
por: Ferreira, Maria Daniela, et al.
Publicado: (2023) -
Liposome-Derived Nanosystems for the Treatment of Behavioral and Neurodegenerative Diseases: The Promise of Niosomes, Transfersomes, and Ethosomes for Increased Brain Drug Bioavailability
por: Pires, Patrícia C., et al.
Publicado: (2023) -
Direct and Reverse Pluronic Micelles: Design and Characterization of Promising Drug Delivery Nanosystems
por: Naharros-Molinero, Almudena, et al.
Publicado: (2022) -
Intranasal administration of a stapled relaxin‐3 mimetic has anxiolytic‐ and antidepressant‐like activity in rats
por: Marwari, Subhi, et al.
Publicado: (2019) -
Antidepressants, anxiolytics, and hypnotics in pregnancy and lactation
por: Ram, Daya, et al.
Publicado: (2015)